Skip to main content
. 2017 Nov 16;143(11):1092–1097. doi: 10.1001/jamaoto.2017.1618

Table 1. Patient Demographics and Lesion Features.

Demographics and Lesion Feature No. (%)a Effect Size (95% CI)
ECD
(n = 26)b
SP
(n = 20)
Age at surgery, median (range), y 59 (21 to 83) 56 (18 to 72) 0.07 (−0.52 to 0.65)
Sex
Male <10 <10 0.02 (−0.11 to 0.44)
Female 21 (82) 12 (60)
Lesion laterality
Right 16 (62) 11 (55) 0.02 (−0.26 to 0.30)
Left 10 (38) 9 (45)
Pathologic finding
PA 15 (58) 12 (60) 0.02 (−0.07 to 0.47)
WT <10 <10
BCA <10 <10
Oncocytoma <10 <10
OPC <10 <10
Lesion size, mean (SD), cm 2.2 (0.9) 2.3 (1.1) −0.10 (−0.68 to 0.48)
Margin status
Positive marginc <10 <10 0.02 (−0.26 to 0.30)
Negative margin 21 (81) 17 (85)
Follow-up, median (range), d 29 (0 to 419) 132 (3 to 508) −0.30 (−0.88 to 0.29)

Abbreviations: BCA, basal cell adenoma; ECD, extracapsular dissection; OPC, oncocytic papillary carcinoma; PA, pleomorphic adenoma; SP, superficial parotidectomy; WT, Warthin tumor.

a

Cell sizes less than 10 are hidden per outcomes research policy to protect patient identity.

b

Percentages may not add to 100% owing to rounding.

c

Margins were called positive if there was inked tumor capsule at the margins.